Filtered By:
Vaccination: Hepatitis Vaccine

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 557 results found since Jan 2013.

Recommendations for modernizing infant vaccination schedules with combination vaccines in Colombia and Peru
The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new vaccines with more antigens remain apparent in parts of these countries, where vaccine-preventable diseases in infants continue to be a major problem. The challenges include the heterogeneity of vaccine coverage within each country and in neighboring countries, which can contribute to poor rates of vaccination coverage; the adverse impact of the inward migration of unvaccinated individuals, which has favored the re-emergence of...
Source: Pan American Journal of Public Health - February 2, 2023 Category: International Medicine & Public Health Authors: Carlos Torres-Martinez Eduardo Chaparro Ana-Cristina Mari ño Luiza Helena Falleiros-Arlant Germ án Camacho-Moreno Mar ía E Castillo Carlos Garces Wilfrido Coronell Roberto Somocurcio Source Type: research

Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections
Mol Biotechnol. 2023 Jan 31. doi: 10.1007/s12033-023-00679-1. Online ahead of print.ABSTRACTNovel effective drugs or therapeutic vaccines have been already developed to eradicate viral infections. Some non-viral carriers have been used for effective drug delivery to a target cell or tissue. Among them, cell penetrating peptides (CPPs) attracted a special interest to enhance drug delivery into the cells with low toxicity. They were also applied to transfer peptide/protein-based and nucleic acids-based therapeutic vaccines against viral infections. CPPs-conjugated drugs or vaccines were investigated in several viral infectio...
Source: Herpes - January 31, 2023 Category: Infectious Diseases Authors: Niloofar Khairkhah Ali Namvar Azam Bolhassani Source Type: research

Viruses, Vol. 15, Pages 392: Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
uan With technological advancements enabling globalization, the intercontinental transmission of pathogens has become much easier. Respiratory viruses are one such group of pathogens that require constant monitoring since their outbreak leads to massive public health crises, as exemplified by the influenza virus, respiratory syncytial virus (RSV), and the recent coronavirus disease 2019 (COVID-19) outbreak caused by the SARS-CoV-2. To prevent the transmission of these highly contagious viruses, developing prophylactic tools, such as vaccines, is of considerable interest to the scientific community. Virus-like particles...
Source: Viruses - January 30, 2023 Category: Virology Authors: Ki-Back Chu Fu-Shi Quan Tags: Review Source Type: research

What ’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty
Just over 2 years ago, the first COVID-19 vaccines arrived—and a roller coaster ride of hope and science began. It soon became clear that although the vaccines protected against severe disease, their ability to fend off infection was limited and faded fast. Meanwhile, SARS-CoV-2 began to evolve rapidly to elude immunity. By now, many people have had four or five vaccine doses, including an updated booster tailored to Omicron strains that was introduced last fall. Now, regulators and scientists are debating the near-term future. How often will we need booster doses and who should receive them? Should vaccines continu...
Source: Science of Aging Knowledge Environment - January 25, 2023 Category: Geriatrics Source Type: research

COVID-19 vaccination and liver disease
World J Gastroenterol. 2022 Dec 28;28(48):6791-6810. doi: 10.3748/wjg.v28.i48.6791.ABSTRACTVarious vaccines against severe acute respiratory syndrome coronavirus 2 have been developed in response to the coronavirus disease 2019 (COVID-19) global pandemic, several of which are highly effective in preventing COVID-19 in the general population. Patients with chronic liver diseases (CLDs), particularly those with liver cirrhosis, are considered to be at a high risk for severe COVID-19 and death. Given the increased rates of disease severity and mortality in patients with liver disease, there is an urgent need to understand the...
Source: World Journal of Gastroenterology - January 12, 2023 Category: Gastroenterology Authors: Sotaro Ozaka Takashi Kobayashi Kazuhiro Mizukami Kazunari Murakami Source Type: research